BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:MTX325 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of MTX325\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07630545-1683@assetmemo.bio
DTSTAMP:20261121T005428Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:MTX325: Phase 1 readout est. (NCT07630545)
DESCRIPTION:MTX325\, phase 1\, Parkinson's Disease.\nStudy: A Phase I Study
  in Healthy Volunteers and Parkinson's Disease (PD) Patients.\nEstimated p
 rimary completion: 30 June 2027. This is a ClinicalTrials.gov estimate\, n
 ot a confirmed readout date\, and it can move.\nDrug page: https://assetme
 mo.bio/drug/mtx325#upcoming-events\nRegistry record: https://clinicaltrial
 s.gov/study/NCT07630545
URL:https://assetmemo.bio/drug/mtx325#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
